Effect of Low Dose Galactose on Glycaemia and Glucose Kinetics
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 25
- 试验地点
- 1
研究概览
简要总结
This project will establish the degree to which adding low-dose galactose to a meal can control blood sugar levels. People will consume standardised glucose drinks (75g glucose, as an oral glucose tolerance test). People will consume these with and without the addition of galactose, and with the addition of another sugar (fructose) for an extra comparison. The investigators will use state-of-the-art labelling methods (dual stable isotope technology) to follow what happens to the glucose that is ingested and understand what happens to sugar being released by the liver and sugar being taken up by other tissues like the muscles. These methods can tell the investigators how the addition of galactose can control blood sugar levels. For example, the galactose could slow down the appearance of glucose from the gut and/or liver released into the blood, or it could increase the disappearance of glucose from the blood into muscles. The investigators will measure the appearance of the label on exhaled breath, which will establish whether ingested sugar is stored, or burned as fuel. The investigators will also explore other potential ways in which galactose might control blood sugar levels by measuring key hormones and metabolites that contribute to blood sugar control (for example, insulin, fatty acids, and incretin hormones which potentiate insulin secretion). This additional evidence of how galactose can control blood sugar levels will provide the understanding required to best make use of this approach across a variety of settings.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age: 18 years and above;
- •Normoglycaemic (fasting glucose <6.1 mmol/L)
- •Body mass index: 18.5-30 kg/m2
排除标准
- •weight instability (>5% change within last 3 months);
- •pregnant or lactating;
- •following a very low-carbohydrate (ketogenic) diet;
- •diagnosis of diabetes or prediabetes, or any other metabolic disease;
- •dietary intolerances or allergies, or to any other study procedures;
- •disorders in the ability to metabolise galactose or fructose (e.g., galactosemias);
- •diagnosis of any gastrointestinal disorders;
- •any other condition/medications that could introduce bias;
- •unable to understand and follow study procedures
研究组 & 干预措施
CONTROL
75 g oral glucose tolerance test
干预措施: Glucose Powder (Dietary Supplement)
GALACTOSE
75 g oral glucose tolerance test plus 7.5 g galactose
干预措施: Glucose Powder (Dietary Supplement)
FRUCTOSE
75 g oral glucose tolerance test plus 7.5 g fructose
干预措施: Glucose Powder (Dietary Supplement)
GALACTOSE
75 g oral glucose tolerance test plus 7.5 g galactose
干预措施: galactose (Dietary Supplement)
FRUCTOSE
75 g oral glucose tolerance test plus 7.5 g fructose
干预措施: fructose (Dietary Supplement)
研究者
Javier Gonzalez
Professor of Nutrition and Metabolism
University of Bath
